ArticleFrontiers in immunology2023

Resistance to immune checkpoint inhibitors in advanced lung cancer: Clinical characteristics, potential prognostic factors and next strategy.

Jiebai Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.